Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains

被引:27
作者
Marlowe, N
Flys, T
Hackett, J
Schumaker, M
Jackson, JB
Eshleman, SH
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Celera Diagnost, Alameda, CA 94502 USA
[3] Abbott Labs, AIDS Res & Retrovirus Discovery, Abbott Pk, IL 60064 USA
关键词
D O I
10.1089/aid.2004.20.1119
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sequence variation in the gag p6 region in subtype B HIV-1 has been associated with changes in viral replication capacity and antiretroviral drug susceptibility. We examined sequence variation in the HIV-1 gag p6 region using plasma samples from 22 individuals with non-subtype B HIV-1 infection [subtypes A, C, D, F, and G, and circulating recombinant forms (CRFs) CRF01-AE and CRF02_AG]. An additional 105 gag sequences from the Los Alamos National Laboratory database were also analyzed. Extensive length variation was observed in the p6 gag region. Specific patterns of insertions and deletions were observed in different subtypes and CRFs, and no two subtypes or CRFs had the same general pattern. PTAP duplications were more common in subtype C than other strains ( 3 of 14 in subtype C vs. 2 of 113 in other strains, p = 0.004), and KQE duplications were seen only in subtype B. Further studies are needed to determine whether such genotypic differences influence viral replication capacity, antiretroviral drug susceptibility, or other phenotypic properties of these strains.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 20 条
  • [1] Polymorphism of HIV type 1 Gag p7/p1 and p1/p6 cleavage sites: Clinical significance and implications for resistance to protease inhibitors
    Bally, F
    Martinez, R
    Peters, S
    Sudre, P
    Telenti, A
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) : 1209 - 1213
  • [2] BATES C, 2003, 12 INT HIV DRUG RES
  • [3] BATES MP, 2003, 43 INT C ANT AG CHEM
  • [4] Proline residues in human immunodeficiency virus type 1 p6Gag exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins
    Dettenhofer, M
    Yu, XF
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (06) : 4696 - 4704
  • [5] Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287
  • [6] Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients
    Gallego, O
    de Mendoza, C
    Corral, A
    Soriano, V
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (03) : 1245 - 1247
  • [7] Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors
    Gatanaga, H
    Suzuki, Y
    Tsang, H
    Yoshimura, K
    Kavlick, MF
    Nagashima, K
    Gorelick, RJ
    Mardy, S
    Tang, C
    Summers, MF
    Mitsuya, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) : 5952 - 5961
  • [8] EFFECT OF MUTATIONS AFFECTING THE P6 GAG PROTEIN ON HUMAN-IMMUNODEFICIENCY-VIRUS PARTICLE RELEASE
    GOTTLINGER, HG
    DORFMAN, T
    SODROSKI, JG
    HASELTINE, WA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) : 3195 - 3199
  • [9] P6(GAG) IS REQUIRED FOR PARTICLE-PRODUCTION FROM FULL-LENGTH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MOLECULAR CLONES EXPRESSING PROTEASE
    HUANG, MJ
    ORENSTEIN, JM
    MARTIN, MA
    FREED, EO
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (11) : 6810 - 6818
  • [10] Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs
    Kaufmann, GR
    Suzuki, K
    Cunningham, P
    Mukaide, M
    Kondo, M
    Imai, M
    Zaunders, J
    Cooper, DA
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (06) : 487 - 497